Assembly of 4-aminoquinolines via palladium catalysis: A mild and convenient alternative to SNAr methodology

Journal of Organic Chemistry

Volumn 72, Issue 6, 2007, Pages 2232-2235

  Margolis, Brandon J ^a   Long, Kimberly A ^a   Laird, Dana L T ^a   Ruble, J Craig ^a   Pulley, Shon R ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYST ACTIVITY; CHEMICAL BONDS; PALLADIUM COMPOUNDS; SYNTHESIS (CHEMICAL);

4-AMINOQUINOLINES; ITERATIVE SCREENING PARADIGM; MEDICINAL CHEMISTRY;

NITROGEN COMPOUNDS;

4 AMINOQUINOLINE DERIVATIVE; AMINE; PALLADIUM;

ARTICLE; CATALYSIS; CHEMICAL ANALYSIS; CHEMICAL BOND; CHEMICAL REACTION; CHEMICAL STRUCTURE; SYNTHESIS;

AMINES; AMINOQUINOLINES; CATALYSIS; METHODS; PALLADIUM; QUINOLINES;

EID: 33947247616     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo062168u     Document Type: Article

References (27)

1. Chloroquine exemplifies a class of 4-AQ antimalarial agents. Also see: (a) O'Neill, P. M.; Ward, S. A.; Berry, N. G.; Jeyadevan, J. P.; Biagini, G. A.; Asadollaly, E.; Park, K. B.; Bray, P. G. Curr. Top. Med. Chem. 2006, 6 (5), 479-507.
2. (b) Madrid, P. B.; Sherrill, J.; Liou, A. P.; Weisman, J. L.; DeRisi, J. L.; Guy, R. K. Bioorg. Med. Chem. Lett. 2005, 15, 1015-1018.
3. (c) Pradines, B.; Tall, F.; Ramiandrasoa, A.; Spiegel, C.; Sokhna, C.; Fusai, J.; Mosnier, J.; Daries, W.; Trape, J. F.; Kunesch, G.; Parzy, D.; Rogier, C. J. Antimicrob. Chemother. 2006, 57 (6), 1093-1099.
4. (d) Biot, C.; Daher, W.; Chavain, N.; Fandeur, T.; Khalife, J.; Dive, D.; De Clercq, E. J. Med. Chem. 2006, 49 (9), 2845-2849.
5. Ruchelman, A. L.; Singh, S. K.; Abhijit, R.; Wu, X. H.; Yang, J.; Li, T.; Liu, A.; Liu, L. F.; LaVoie, E. J. Bioorg. Med. Chem. 2003, 11, 2061-2073.
6. SKF-97574 was in Phase III clinical trials for the treatment of upper gastrointestinal ulcers. (a) Leach, C. A.; Brown, T. H.; Ife, R. J.; Keeling, D. J.; Parsons, M. E.; Theobald, C. J.; Wiggall, K. J. J. Med. Chem. 1995, 38 (14), 2748-2762.
7. (b) Atkins, R. J.; Breen, G. F.; Crawford, L. P.; Grinter, T. J.; Harris, M. A.; Hayes, J. F.; Moores, C. J.; Saunders, R. N.; Share, A. C.; Walsgrove, T. C.; Wicks, C. Org. Process Res. Dev. 1997, 1, 185-197.
8. 3 antagonists, see: Turner, S. C.; Esbenshade, T. A.; Bennani, Y. L.; Hancock, A. A. Bioorg. Med. Chem. Lett. 2003, 13, 2131-2135.
9. (a) Surrey, A. R.; Hammer, H. F. J. Am. Chem. Soc. 1946, 68, 113-116.
10. (b) Surrey, A. R.; Cutler, R. A. J. Am. Chem. Soc. 1951, 73, 2623-2626.
11. (a) Hartwig, J. F. In Handbook of Organopalladium Chemistry for Organic Synthesis; Negiahi, E. I., Ed.; Wiley-Interscience: New York, 2002; Vol. l, p 1051.
12. (b) Muci, A. R.; Buchwald, S. L. Top. Curr. Chem. 2002, 219, 131-209.
13. Yields are reported with a 95% measurement error prediction interval. The prediction interval reflects both the uncertainty in the measure for each reaction condition as well as the two-point calibration used within each batch. The interval was derived assuming normally distributed errors for the AUC measurements, scaling of the reaction product AUC values to the spiked internal standard AUC value within each injection, a correlation coefficient of 0.7 between the AUC of the product of interest and the internal standard across repeated injections, and a constant AUC total coefficient of variation estimated from the between and within batch variance from the spiked internal standard AUC values.
14. Aldrich Chem. Files 2006, 6 (3).
15. Marion, N.; Ecarnot, E. C.; Navarro, O.; Amoroso, D.; Bell, A.; Nolan, S. P. J. Org. Chem. 2006, 71, 3816-3821.
16. Netherton, M. R.; Fu, G. C. Org. Lett. 2001, 3, 4295-4298.
17. Strem Catalog No. 20 (2004-2006).
18. During the course of our investigation, Beletskaya and co-workers reported the animation of 4-chloroquinoline derivatives under the influence of palladium catalysis employing either BINAP or DPPF derivatives as ligands, see: Beletskaya, I. P.; Tsvetkob, A. V.; Latyshev, G. V.; Lukashev, N. V. Russ. Chem. Bull. Int. Ed. 2005, 54 (1), 215-219.
19. (a) Davies, D. T.; Elder, J. S.; Forrest, A. K.; Jarvest, R. L.; Pearson, N. D.; Sheppard, R. J. WO 2004/014361A1 (PCT Int. Appl.), Feb 19, 2004.
20. (b) Watz, A. J.; Sundberg, R. J. J. Org. Chem. 2000, 65 (23), 8001-2010.
21. (c) Gordon, H. J.; Martin, J. C.; McNab, H. J. Chem. Soc., Chem. Commun. 1983, 957-958.
22. (a) Kubo, K.; Shimizu, T.; Ohyama, S.; Murooka, H.; Iwai, A.; Nakamura, K.; Hasegawa, K.; Kobayashi, Y.; Takahashi, N.; Takahashi, K.; Kato, S.; Izawa, T.; Isoe, T. J. Med. Chem. 2005, 48 (5), 1359-1366.
23. (b) Ruchelman, A. L.; Houghton, P. J.; Zhou, N.; Liu, A.; Liu, L. F.; LaVoie, E. J. J. Med. Chem. 2005, 48 (3), 792-804.
24. (c) Osawa, T.; Kubo, K.; Murooka, H.; Nakajima, T. WO 98/47873 (PCT Int. Appl.), Oct 29, 1998.
25. (d) Nakajima, T.; Kamimasahara, M.; Matsunaga, N. JP 2002/030083A (Jpn. Kokai Tokkyo Koho), Jan 29, 2002.
26. Axten, J. M.; Daines, R. A.; Davies, D. T.; Gallagher, T. F.; Jones, G. E.; Miller, W. H.; Pearson, N. D.; Pendrak, I. (PCT Int. Appl) WO2004/ 002992 A1, Jan 8, 2004.
27. Wagaw, S.; Rennels, R. A.; Buchwald, S. L. J. Am. Chem. Soc. 1997, 119, 8451-8458.